Pay in 4 interest-free payments of $6.88 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
As a synthetic analog, DSIP exhibits poor oral bioavailability and is typically administered via parenteral routes for research purposes
However, it was not possible to establish whether these histological effects were solely determined by reductions in body weight
In parallel, the landscape of pharmacological therapies for T2DM and (to a lesser extent) obesity has expanded in recent decades with new classes of molecules coming into the market
Pfizer challenges Novo and Lilly: GLP-1 drug available for pre-order in China Pfizer is strengthening its position in the rapidly growing weight-loss sector Pfizers GLP-1 weight management treatment Xianweiying, is reportedly available for pre-order in China in the wake of intensifying competition with rivals in a market analysis expected to be worth billions of dollars
US$ 28.88
US$ 28.29
US$ 29.68
US$ 22.97
US$ 21.23
US$ 22.68
US$ 24.31
US$ 21.68
US$ 25.16
